Vaccinia virus-induced microtubule-dependent cellular rearrangements

被引:51
作者
Schepis, A
Schramm, B
de Haan, CAM
Locker, JK
机构
[1] European Mol Biol Lab, Cell Biol & Biophys Programme, D-69117 Heidelberg, Germany
[2] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Div Virol, NL-3583 CL Utrecht, Netherlands
关键词
actin; cell shape; microtubules; modified vaccinia virus ankara; vaccinia virus;
D O I
10.1111/j.1600-0854.2005.00381.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although infection with vaccinia virus (VV) is known to affect the cytoskeleton, it is not known how this affects the cellular architecture or whether the attenuated modified VV ankara (MVA) behaves similar to wild-type VV (wtVV). In the present study, we therefore compared effects of wtVV and MVA infection on the cellular architecture. WtVV-infection induces cell rounding early in infection, which coincides with the retraction of microtubules (MTs) and intermediate filaments from the cellular periphery, whereas mitochondria and late endosomes cluster around the nucleus. Nocodazole treatment demonstrates that cell rounding and organelle clustering require intact MTs. At the onset of virus assembly late in infection, cells reflatten, a process that coincides with the regrowth of MTs into the cellular periphery. We find that the actin network undergoes several rearrangements that occur sequentially in time and that closely follow the cell-shape changes. Unexpectedly, these actin changes are blocked or reversed upon nocodazole treatment, indicating that intact MTs are also responsible for the wtVV-induced actin rearrangements. Finally, MVA infection does not induce any of these cellular changes. Because this virus lacks a substantial number of VV genes, MVA opens up a system to search for the molecules involved in wtVV-induced cellular changes; in particular, those that may regulate actin/MT interactions.
引用
收藏
页码:308 / 323
页数:16
相关论文
共 52 条
[1]   The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication [J].
Andrade, AA ;
Silva, PNG ;
Pereira, ACTC ;
De Sousa, LP ;
Ferreira, PCP ;
Gazzinelli, RT ;
Kroon, EG ;
Ropert, C ;
Bonjardim, CA .
BIOCHEMICAL JOURNAL, 2004, 381 :437-446
[2]   The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses [J].
Antoine, G ;
Scheiflinger, F ;
Dorner, F ;
Falkner, FG .
VIROLOGY, 1998, 244 (02) :365-396
[3]   STUDIES ON MECHANISMS OF VACCINIA VIRUS CYTOPATHIC EFFECTS .1. INHIBITION OF PROTEIN-SYNTHESIS IN INFECTED-CELLS IS ASSOCIATED WITH VIRUS-INDUCED RNA-SYNTHESIS [J].
BABLANIAN, R ;
ESTEBAN, M ;
BAXT, B ;
SONNABEND, JA .
JOURNAL OF GENERAL VIROLOGY, 1978, 39 (JUN) :391-402
[4]   Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses [J].
Belyakov, IM ;
Earl, P ;
Dzutsev, A ;
Kuznetsov, VA ;
Lemon, M ;
Wyatt, LS ;
Snyder, JT ;
Ahlers, JD ;
Franchini, G ;
Moss, B ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9458-9463
[5]  
Bulinski JC, 1997, J CELL SCI, V110, P3055
[6]   POXVIRUS PATHOGENESIS [J].
BULLER, RML ;
PALUMBO, GJ .
MICROBIOLOGICAL REVIEWS, 1991, 55 (01) :80-122
[7]   Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: Propagation and generation of recombinant viruses in a nonhuman mammalian cell line [J].
Carroll, MW ;
Moss, B .
VIROLOGY, 1997, 238 (02) :198-211
[8]  
Chang W, 2001, J CELL SCI, V114, P2879
[9]   Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product [J].
Dobbelstein, M ;
Shenk, T .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6479-6485
[10]   Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro [J].
Dorrell, L ;
O'Callaghan, CA ;
Britton, W ;
Hambleton, S ;
McMichael, A ;
Smith, GL ;
Rowland-Jones, S ;
Blanchard, TJ .
VACCINE, 2000, 19 (2-3) :327-336